We thank Drs Tsikas and Cooper for their interest in our recent publication on plasma H 2 S reduction in preeclampsia ( Figure 1A 1 ) . They questioned the merit of the widely used methylene blue assay to measure plasma H 2 S levels. We agree that this assay may overestimate the amount of free H 2 S present in plasma. 2 However, the experimental design in our study investigated the relative change in plasma H 2 S levels between normal pregnancy and preeclampsia. Furthermore, the reduction in plasma H 2 S in preeclampsia compared with normal pregnancy was accompanied by decreased CSE mRNA and protein expression ( Figure 1 1 ). Therefore, 3 independent observations (RNA, protein, activity) provide compelling evidence of a net loss of H 2 S activity in preeclampsia.
The cytoprotective pathway of heme oxygenase-1 and cystathionine γ-lyase (CSE), which generate carbon monoxide (CO) and hydrogen sulfide (H 2 S), respectively, hold promise for preeclampsia therapy because of their unique ability to suppress the antiangiogenic state, systemic inflammation, and oxidative stress. 1, 3 We respectfully disagree with the suggestion that because an overall decrease in total reactive sulfur maybe modest, this is inconsistent with the H 2 S/CSE role in preeclampsia. The changes in H 2 S levels between preeclampsia and normal pregnancy were significant ( Figure 1A ). 1 More importantly, a reduction of H 2 S in pregnant mice administered DL-propargylglycine to inhibit CSE activity, resulted in hypertension, liver damage, and abnormal labyrinth vascularization in the placenta, leading to fetal growth restriction and preeclampsia-like features. 1 As is true with other labile gases, the focus needs to remain on the biological relevance. In agreement with our results, Shen and colleagues demonstrated that free H 2 S levels and acid-labile sulfide in CSE deficient (CSE −/− ) mice were reduced compared with wildtype animals (see Figure 5 2 ). The acid labile pool was in the low micromolar range and likely liberated and detected by the methylene blue method along with free H 2 S as was the case in our study. The change, whether modest or large, is associated with the CSE −/− mouse exhibiting abnormal vascular phenotype. 4 Consistent with our notion of loss of CSE as a pathogenic mechanism, supplementation with H 2 S reverses abnormalities in the mouse, suggesting therapeutic potential. 1 The importance of H 2 S in preventing damage is further supported by a recent study showing that H 2 S attenuates adenovirusmediated overexpression of soluble Flt-1-induced hypertension and renal damage in nonpregnant Sprague-Dawley rats. 5 Further transgenic studies are needed to delineate the relative importance of placental-and endothelial-specific knockdown of CSE.
A more precise determination of the distribution of H 2 S in its various biochemical forms using advanced analytic methods 2 is underway on well-defined longitudinal clinical samples in collaboration with a leading H 2 S analytic scientist. Absolute values are important in studying the physiology of endogenous H 2 S and in determining the accurate dose of H 2 S donors for biological systems. Any future pharmacological safety studies on H 2 S donors in pregnant women will have to precisely measure H 2 S levels before the Food and Drug Administration could approve a clinical trial. There is therefore a need to develop high-throughput methods to accurately measure the labile gases in biological fluids.
In conclusion, our studies show that the restoration of effective endogenous cytoprotective pathway 1,3 now offers a new paradigm to resolve preeclampsia and protect mother and baby.
